Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term.
New antibody therapy shows promise in combating kidney transplant rejection
- Post author:
- Post published:May 27, 2024
- Post category:uncategorized